ABOUT NINA Medical


Our Vision

For too long, men have had to choose between invasive treatments or delay in fear and discomfort. With NINA Medical’s truly non-invasive approach, there is no need to compromise.
Patients will remain awake and comfortable while focused ultrasound energy is precisely guided to gently reduce the prostate, enabling a reassuring patient-centered experience.
Unlike all existing procedures that enter through the urethra or rectum, NINA’s treatment reaches the prostate from outside the body, through the perineum, without penetration. The unique acoustic window of the perineum allows safe treatment of the prostate while sparing sensitive surrounding organs and tissue.
NINA’s technological breakthrough extends far beyond clinical benefit; it opens a vast new segment of the market. Millions of men who delay treatment finally have a reason to seek care early.

Our Team



Co-founder, Clinical Applications Manager

Alexander Volovick


Co-founder and CEO

Shmuel Ben-Ezra


Co-founder and CTO

Yoni Hertzberg, PhD, MBA


President, U.S. Operations

John W. Linn


Project Manager

Ariella Cohen


Chief Clinical and Regulatory Officer

Ketty Shkolnik, PhD

Board of Directors


Board Member

Ayelet Barneah Alsheich

Board Member (Chairman)

Christos Monovoukas

Board Member

Moshe Shoham, PhD

Board Member

Howard Jonas

Advisory Board


Medical Director

Gilad E. Amiel, MD

Rambam Medical Center, Israel

Mark Emberton, MD

University College Hospital, London

Dean S. Elterman, MD

University of Toronto, Canada

Howard B. Goldman, MD

Cleveland Clinic, OH
All Rights Reserved © Nina Medical 2020